文献速递生殖医学

囊胚培养后废弃培养基中miRNA检测定制方案的建立与验证:寻找植入生物标志物

Definition and validation of a custom protocol to detect miRNAs in the spent media after blastocyst culture: searching for biomarkers of implantation.
PubMed 文献 · Hum Reprod · 2019-01-01

本研究分两阶段于2015年9月至2017年12月开展:第一阶段从6枚捐赠囊胚的内细胞团和滋养外胚层定义miRNome并设计快速定制方案;第二阶段在三个IVF中心收集239份废弃囊胚培养基样本,对107份未植入和114份已植入整倍体囊胚样本比较,校正胚胎形态和完全扩张日后无显著关联。

要点

  • 定制方案可在3小时内从10份废弃囊胚培养基中检测10种miRNA。
  • 第二阶段未校正时未植入与已植入整倍体囊胚间miRNA检测和相对定量有显著差异。
  • 校正胚胎形态和完全发育日后,未确认显著关联,方案预测力受限。

核心结论

  • 对数据按囊胚质量和完全扩张日校正后,基于废弃囊胚培养基中10种选定miRNA检测的快速、廉价、可重复且易用方案的预测力受到妨碍。

研究设计与样本

  • 研究分两阶段于2015年9月至2017年12月进行:第一阶段从6枚捐赠囊胚的内细胞团和对应全滋养外胚层定义人囊胚miRNome,并设计定制方案;第二阶段在三个IVF中心收集239份已植入整倍体囊胚和未植入整倍体囊胚的废弃培养基,排除18份来自差质量囊胚的样本后,分析107份未植入和114份已植入样本并通过逻辑回归校正数据。

主要发现

  • TLDA卡片方案的假阳性率高于Exiqon方案(5.6% vs 2.8%)。
  • 两种方案在内细胞团和滋养外胚层中均检测到44种miRNA,仅内细胞团检测到1种,仅滋养外胚层检测到24种。
  • 混合废弃培养基中检测到29种miRNA:8种仅来自未植入组,8种仅来自已植入组,13种两组均检测到。
  • 29种miRNA中,24种(82.7%)此前用Exiqon方案在内细胞团和滋养外胚层中均检测到,2种(6.9%)此前仅在滋养外胚层检测到,3种(10.3%)此前从未检测到。
  • 第二阶段未校正时,未植入组与已植入组在miRNA检测和相对定量上显示显著差异;校正胚胎形态和完全发育日(即废弃培养基收集日)后,未确认显著关联。

局限性

  • 本研究未专门评估外泌体miRNA,降低了识别功能性miRNA的机会。
  • 需要离体实验确认miRNA在介导与子宫内膜细胞对话中的作用,且需进一步评估更高通量技术用于临床废弃囊胚培养基样本的miRNA分析。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Can miRNAs be reliably detected in the spent blastocyst media (SBM) after IVF as putative biomarkers of the implantation potential of euploid embryos? SUMMARY ANSWER: Adjustment of the data for blastocyst quality and the day of full-expansion hinders the predictive power of a fast, inexpensive, reproducible and user-friendly protocol based on the detection of 10 selected miRNAs from SBM. WHAT IS KNOWN ALREADY: Euploidy represents so far the strongest predictor of blastocyst competence. Nevertheless, ~50% of the euploid blastocysts fail to implant. Several studies across the years have suggested that a dialogue exists between the embryo and the endometrium aimed at the establishment of a pregnancy. MicroRNAs have been proposed as mediators of such a dialogue and investigated in this respect. Several expensive, time-consuming and complex protocols have been adopted and promising results have been produced, but conclusive evidence from large clinical studies is missing. STUDY DESIGN, SIZE, DURATION: This study was conducted in two phases from September 2015 to December 2017. In Phase 1, the human blastocyst miRNome profile was defined from the inner cell mass (ICM) and the corresponding whole-trophectoderm (TE) of six donated blastocysts. Two different protocols were adopted to this end. In parallel, 6 pools of 10 SBM each were run (3 from only implanted euploid blastocysts, IEBs; and 3 from only not-implanted euploid blastocysts, not-IEBs). A fast, inexpensive and user-friendly custom protocol for miRNA SBM profiling was designed. In Phase 2, 239 SBM from IEB and not-IEB were collected at three IVF centres. After 18 SBM from poor-quality blastocysts were excluded from the analysis, data from 107 SBM from not-IEB and 114 from IEB were produced through the previously developed custom protocol and compared. The data were corrected through logistic regressions. PARTICIPANT/MATERIALS, SETTINGS, METHODS: Donated blastocysts underwent ICM and whole-TE isolation. SBM were collected during IVF cycles characterized by ICSI, blastocyst culture in a continuous media, TE biopsy without zona pellucida opening in Day 3, quantitative PCR (qPCR)-based aneuploidy testing and vitrified-warmed single euploid embryo transfer. Not-IEB and IEB were clustered following a negative pregnancy test and a live birth, respectively. The Taqman Low Density Array (TLDA) cards and the Exiqon microRNA human panel I+II qPCR analysis protocols were adopted to analyse the ICM and whole-TE. The latter was used also for SBM pools. A custom protocol and plate was then designed based on the Exiqon workflow, validated and finally adopted for SBM analysis in study Phase 2. This custom protocol allows the analysis of 10 miRNAs from 10 SBM in 3 hours from sample collection to data inspection. MAIN RESULTS AND ROLE OF THE CHANCE: The TLDA cards protocol involved a higher rate of false positive results (5.6% versus 2.8% with Exiqon). There were 44 miRNAs detected in the ICM and TE from both the protocols. One and 24 miRNAs were instead detected solely in the ICM and the TE, respectively. Overall, 29 miRNAs were detected in the pooled SBM: 8 only from not-IEB, 8 only from IEB and 13 from both. Most of them (N = 24/29, 82.7%) were also detected previously in both the ICM and TE with the Exiqon protocol; two miRNAs (N = 2/29, 6.9%) were previously detected only in the TE, and three (N = 3/29, 10.3%) were never detected previously. In study Phase 2, significant differences were shown between not-IEB and IEB in terms of both miRNA detection and relative quantitation. However, when the data were corrected for embryo morphology and day of full development (i.e. SBM collection), no significant association was confirmed. LIMITATIONS, REASONS FOR CAUTION: This study did not evaluate specifically exosomal miRNAs, thereby reducing the chance of identifying the functional miRNAs. Ex-vivo experiments are required to confirm the role of miRNAs in mediating the dialogue with endometrial cells, and higher throughput technologies need to be further evaluated for miRNA profiling from clinical SBM samples. WIDER IMPLICATIONS OF THE FINDINGS: Although no clinical predictive power was reported in this study, the absence of invasiveness related with SBM analysis and the evidence that embryonic genetic material can be reliably detected and analysed from SBM make this waste product of IVF an important source for further investigations aimed at improving embryo selection. STUDY FUNDING/COMPETING INTEREST(S): This project has been financially supported by Merck KgaA (Darmstadt, Germany) with a Grant for Fertility Innovation (GFI) 2015. The authors have no conflict of interest to declare related with this study. TRIAL REGISTRATION NUMBER: None.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Cimadomo D, Rienzi L, Giancani A, et al. Definition and validation of a custom protocol to detect miRNAs in the spent media after blastocyst culture: searching for biomarkers of implantation. Hum Reprod. 2019. PMID: 31419301. doi:10.1093/humrep/dez119

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。